{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:33:59Z","timestamp":1787931239870,"version":"build-2784847793"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Biochemistry and Biophysics"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.abb.2022.109489","type":"journal-article","created":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T01:57:33Z","timestamp":1670896653000},"page":"109489","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Anti-proliferative, pro-apototic and anti-migratory properties of HDAC inhibitor PXD-101 on osteosarcoma cell lines"],"prefix":"10.1016","volume":"734","author":[{"given":"Michela","family":"Rossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"De Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Di Giuseppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Battafarano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Di Gregorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Terreri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Marampon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Minisola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Del Fattore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.abb.2022.109489_bib1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/ijc.24320","article-title":"International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons","volume":"125","author":"Mirabello","year":"2009","journal-title":"Int. J. Cancer"},{"issue":"9574","key":"10.1016\/j.abb.2022.109489_bib2","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/S0140-6736(07)60781-8","article-title":"Metastasis: recent discoveries and novel treatment strategies","volume":"369","author":"Eccles","year":"2007","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.abb.2022.109489_bib3","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s10585-011-9384-x","article-title":"Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literature","volume":"28","author":"PosthumaDeBoer","year":"2011","journal-title":"Clin. Exp. Metastasis"},{"issue":"1","key":"10.1016\/j.abb.2022.109489_bib4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1200\/JCO.1987.5.1.21","article-title":"Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial","volume":"5","author":"Eilber","year":"1987","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.abb.2022.109489_bib5","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1093\/annonc\/mdt252","article-title":"Limb preservation surgery with extracorporeal irradiation in the management of malignant bone tumor: the oncological outcomes of 101 patients","volume":"24","author":"Hong","year":"2013","journal-title":"Ann. Oncol."},{"issue":"11","key":"10.1016\/j.abb.2022.109489_bib6","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nrc3838","article-title":"Translational biology of osteosarcoma","volume":"14","author":"Kansara","year":"2014","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.abb.2022.109489_bib7","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.jpeds.2008.11.030","article-title":"Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression","volume":"154","author":"Patino-Garcia","year":"2009","journal-title":"J. Pediatr."},{"issue":"27","key":"10.1016\/j.abb.2022.109489_bib8","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1200\/JCO.2007.14.7793","article-title":"High-dose methotrexate in osteosarcoma: let the questions surcease--time for final acceptance","volume":"26","author":"Jaffe","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"10\u201312","key":"10.1016\/j.abb.2022.109489_bib9","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.bbagrm.2010.05.008","article-title":"Histone deacetylase inhibitors: a chemical genetics approach to understanding cellular functions","volume":"1799","author":"Marks","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.abb.2022.109489_bib10","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/jcb.22185","article-title":"Histone deacetylase inhibitors: potential in cancer therapy","volume":"107","author":"Marks","year":"2009","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.abb.2022.109489_bib11","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.canlet.2019.07.009","article-title":"Pro-differentiating and radiosensitizing effects of inhibiting HDACs by PXD-101 (Belinostat) in in vitro and in vivo models of human rhabdomyosarcoma cell lines","volume":"461","author":"Marampon","year":"2019","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.abb.2022.109489_bib12","first-page":"3412","article-title":"Antiproliferative effects of TSA, PXD101 and MS275 in A2780 and MCF7 cells: acetylated histone H4 and acetylated tubulin as markers for HDACi potency and selectivity","volume":"38","author":"Androutsopoulos","year":"2017","journal-title":"Oncol. Rep."},{"issue":"3","key":"10.1016\/j.abb.2022.109489_bib13","first-page":"711","article-title":"Differential effects of PXD101 (belinostat) on androgen-dependent and androgen-independent prostate cancer models","volume":"40","author":"Gravina","year":"2012","journal-title":"Int. J. Oncol."},{"issue":"8","key":"10.1016\/j.abb.2022.109489_bib14","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.nano.2013.05.017","article-title":"Nanoparticles for urothelium penetration and delivery of the histone deacetylase inhibitor belinostat for treatment of bladder cancer","volume":"9","author":"Martin","year":"2013","journal-title":"Nanomedicine"},{"issue":"9","key":"10.1016\/j.abb.2022.109489_bib15","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/mc.22024","article-title":"Growth inhibition of pancreatic cancer cells by histone deacetylase inhibitor belinostat through suppression of multiple pathways including HIF, NFkB, and mTOR signaling in vitro and in vivo","volume":"53","author":"Chien","year":"2014","journal-title":"Mol. Carcinog."},{"issue":"4","key":"10.1016\/j.abb.2022.109489_bib16","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/jcp.24218","article-title":"The cancer-related transcription factor Runx2 modulates cell proliferation in human osteosarcoma cell lines","volume":"228","author":"Lucero","year":"2013","journal-title":"J. Cell. Physiol."},{"issue":"6","key":"10.1016\/j.abb.2022.109489_bib17","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/jcb.21137","article-title":"Mitotic control of RUNX2 phosphorylation by both CDK1\/cyclin B kinase and PP1\/PP2A phosphatase in osteoblastic cells","volume":"100","author":"Rajgopal","year":"2007","journal-title":"J. Cell. Biochem."},{"issue":"12","key":"10.1016\/j.abb.2022.109489_bib18","first-page":"547","article-title":"Osteosarcoma: a meta-analysis and review of the literature","volume":"44","author":"Friebele","year":"2015","journal-title":"Am. J. Orthoped."},{"issue":"2","key":"10.1016\/j.abb.2022.109489_bib19","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/bjc.2014.585","article-title":"Recurrent osteosarcoma with a single pulmonary metastasis: a multi-institutional review","volume":"112","author":"Daw","year":"2015","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.abb.2022.109489_bib20","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s12272-015-0571-1","article-title":"Histone deacetylase inhibitors in hematological malignancies and solid tumors","volume":"38","author":"Chun","year":"2015","journal-title":"Arch Pharm. Res. (Seoul)"},{"issue":"6","key":"10.1016\/j.abb.2022.109489_bib21","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ccr.2011.04.017","article-title":"Mad2 is a critical mediator of the chromosome instability observed upon Rb and p53 pathway inhibition","volume":"19","author":"Schvartzman","year":"2011","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.abb.2022.109489_bib22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ccr.2006.10.019","article-title":"Mad2 overexpression promotes aneuploidy and tumorigenesis in mice","volume":"11","author":"Sotillo","year":"2007","journal-title":"Cancer Cell"},{"issue":"7287","key":"10.1016\/j.abb.2022.109489_bib23","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature08803","article-title":"Mad2-induced chromosome instability leads to lung tumour relapse after oncogene withdrawal","volume":"464","author":"Sotillo","year":"2010","journal-title":"Nature"},{"issue":"22","key":"10.1016\/j.abb.2022.109489_bib24","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.4161\/15384101.2014.962952","article-title":"Mad2 and BubR1 modulates tumourigenesis and paclitaxel response in MKN45 gastric cancer cells","volume":"13","author":"Bargiela-Iparraguirre","year":"2014","journal-title":"Cell Cycle"},{"issue":"3","key":"10.1016\/j.abb.2022.109489_bib25","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1600-0463.2009.02583.x","article-title":"Mitotic arrest defective protein 2 expression abnormality and its clinicopathologic significance in human osteosarcoma","volume":"118","author":"Yu","year":"2010","journal-title":"APMIS"},{"issue":"9","key":"10.1016\/j.abb.2022.109489_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045045","article-title":"Histone deacetylase inhibitors induce epithelial-to-mesenchymal transition in prostate cancer cells","volume":"7","author":"Kong","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.abb.2022.109489_bib27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12964-022-00870-y","article-title":"Regulation of epithelial-mesenchymal transition by protein lysine acetylation","volume":"20","author":"Kong","year":"2022","journal-title":"Cell Commun. Signal."},{"issue":"1","key":"10.1016\/j.abb.2022.109489_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145985","article-title":"A histone deacetylase inhibitor suppresses epithelial-mesenchymal transition and attenuates chemoresistance in biliary tract cancer","volume":"11","author":"Sakamoto","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.abb.2022.109489_bib29","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.molcel.2005.04.006","article-title":"Regulation of tissue-specific and extracellular matrix-related genes by a class I histone deacetylase","volume":"18","author":"Whetstine","year":"2005","journal-title":"Mol. Cell"},{"issue":"6","key":"10.1016\/j.abb.2022.109489_bib30","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.tcb.2008.04.003","article-title":"HDAC6: a key regulator of cytoskeleton, cell migration and cell-cell interactions","volume":"18","author":"Valenzuela-Fernandez","year":"2008","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.abb.2022.109489_bib31","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/msb.2013.33","article-title":"The HDAC interaction network","volume":"9","author":"Livyatan","year":"2013","journal-title":"Mol. Syst. Biol."},{"issue":"6","key":"10.1016\/j.abb.2022.109489_bib32","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.3892\/or.2012.2032","article-title":"Upregulation of Mad2 facilitates in vivo and in vitro osteosarcoma progression","volume":"28","author":"Yu","year":"2012","journal-title":"Oncol. Rep."},{"issue":"7","key":"10.1016\/j.abb.2022.109489_bib33","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2174\/1871520615666150304151228","article-title":"RUNX2 and osteosarcoma","volume":"15","author":"Li","year":"2015","journal-title":"Anti Cancer Agents Med. Chem."},{"issue":"6","key":"10.1016\/j.abb.2022.109489_bib34","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.3892\/ol.2015.3124","article-title":"RUNX2 RNA interference inhibits the invasion of osteosarcoma","volume":"9","author":"Zeng","year":"2015","journal-title":"Oncol. Lett."},{"issue":"3","key":"10.1016\/j.abb.2022.109489_bib35","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1007\/s13277-015-4086-7","article-title":"MiR-30a regulates the proliferation, migration, and invasion of human osteosarcoma by targeting Runx2","volume":"37","author":"Zhang","year":"2016","journal-title":"Tumour Biol."},{"issue":"4","key":"10.1016\/j.abb.2022.109489_bib36","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1158\/0008-5472.CAN-04-2128","article-title":"Osterix, a transcription factor for osteoblast differentiation, mediates antitumor activity in murine osteosarcoma","volume":"65","author":"Cao","year":"2005","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.abb.2022.109489_bib37","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41419-022-04545-x","article-title":"Correction to: upregulated osterix promotes invasion and bone metastasis and predicts for a poor prognosis in breast cancer","volume":"13","author":"Yao","year":"2022","journal-title":"Cell Death Dis."},{"issue":"12","key":"10.1016\/j.abb.2022.109489_bib38","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020105279","article-title":"Spindle checkpoint: trapped by the corona, cyclin B1 goes MAD","volume":"39","author":"Conde","year":"2020","journal-title":"EMBO J."},{"issue":"4","key":"10.1016\/j.abb.2022.109489_bib39","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1083\/jcb.201808014","article-title":"CDK1-CCNB1 creates a spindle checkpoint-permissive state by enabling MPS1 kinetochore localization","volume":"218","author":"Hayward","year":"2019","journal-title":"J. Cell Biol."},{"issue":"13","key":"10.1016\/j.abb.2022.109489_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22136865","article-title":"Osteosarcoma and metastasis associated bone degradation-A tale of osteoclast and malignant cell cooperativity","volume":"22","author":"Norregaard","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"18","key":"10.1016\/j.abb.2022.109489_bib41","doi-asserted-by":"crossref","first-page":"7063","DOI":"10.1158\/0008-5472.CAN-09-4291","article-title":"Loss of osteoclasts contributes to development of osteosarcoma pulmonary metastases","volume":"70","author":"Endo-Munoz","year":"2010","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.abb.2022.109489_bib42","first-page":"434","article-title":"The role of osteoclasts and tumour-associated macrophages in osteosarcoma metastasis","volume":"1826","author":"Endo-Munoz","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.abb.2022.109489_bib43","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/pbc.21988","article-title":"Initial testing (stage 1) of vorinostat (SAHA) by the pediatric preclinical testing program","volume":"53","author":"Keshelava","year":"2009","journal-title":"Pediatr. Blood Cancer"},{"issue":"16","key":"10.1016\/j.abb.2022.109489_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13164199","article-title":"Selective targeting of class I histone deacetylases in a model of human osteosarcoma","volume":"13","author":"Torres","year":"2021","journal-title":"Cancers"}],"container-title":["Archives of Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986122003757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986122003757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T06:22:46Z","timestamp":1757744566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003986122003757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":44,"alternative-id":["S0003986122003757"],"URL":"https:\/\/doi.org\/10.1016\/j.abb.2022.109489","relation":{},"ISSN":["0003-9861"],"issn-type":[{"value":"0003-9861","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-proliferative, pro-apototic and anti-migratory properties of HDAC inhibitor PXD-101 on osteosarcoma cell lines","name":"articletitle","label":"Article Title"},{"value":"Archives of Biochemistry and Biophysics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abb.2022.109489","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109489"}}